4.6 Article

GRK5 Deficiency in the Hippocampus Leads to Cognitive Impairment via Abnormal Microglial Alterations

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

SYK coordinates neuroprotective microglial responses in neurodegenerative disease

Hannah Ennerfelt et al.

Summary: Recent studies have highlighted the critical roles of microglia and their receptors in controlling neurotoxic material in neurodegenerative diseases. SYK plays an important role in neuroprotective functions of microglia, with its deletion exacerbating AD deposition and neuropathology. In addition, SYK regulates microglial phagocytosis and DAM acquisition in demyelinating disease.
Review Immunology

Microglia: Immune and non-immune functions

Katharina Borst et al.

Summary: Microglia, as resident macrophages of the CNS, play crucial roles in maintaining brain homeostasis and responding to disease, through intricate bidirectional communication with other brain cells and infiltrating peripheral immune cells. This harmonious cell-cell communication is essential for maintaining tissue health and overcoming pathology such as neuroinflammation.

IMMUNITY (2021)

Review Biochemistry & Molecular Biology

Targeting GRK5 for Treating Chronic Degenerative Diseases

Federica Marzano et al.

Summary: GPCRs, regulated by GRKs, play a key role in transducing extracellular signals. Among GRKs, GRK5 stands out as a multifunctional protein that can regulate GPCRs on the plasma membrane and promote non-canonical signaling in the nucleus, contributing to the pathogenesis of chronic-degenerative disorders in various cell types such as cardiac, tumor, and neuronal cells. Targeting GRK5 may offer potential therapeutic strategies for cancer, cardiovascular, and neurological diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biotechnology & Applied Microbiology

Analysis of Shared Genetic Regulatory Networks for Alzheimer's Disease and Epilepsy

Xiao-Dan Wang et al.

Summary: This study aimed to identify shared genetic networks and hub genes for Alzheimer's disease (AD) and epilepsy. Shared GCMs were significantly enriched in nervous system-related pathways, highlighting potential novel therapeutic targets for both conditions. Hub genes identified through weighted key driver analysis (wKDA) included TRPC1, C2ORF40, NR3C1, KIAA0368, MMT00043109, STEAP1, MSX1, KL, and CLIC6.

BIOMED RESEARCH INTERNATIONAL (2021)

Review Cell Biology

Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease

Jesus Burillo et al.

Summary: This review examines the main molecular mechanisms that may be involved in the connection between type 2 diabetes and neurodegenerative diseases, with a focus on inflammation, endoplasmic reticulum stress, autophagy, and mitochondrial dysfunction.

CELLS (2021)

Article Neurosciences

A current view on Tau protein phosphorylation in Alzheimer's disease

Susanne Wegmann et al.

Summary: The functions of Tau in the central nervous system are regulated by various posttranslational modifications, with phosphorylation being widely recognized as a pathological hallmark in diseases like AD. However, the similarities and heterogeneity of phosphorylation patterns between physiological and pathological Tau make it challenging to identify specific modifications as therapeutic targets and biomarkers.

CURRENT OPINION IN NEUROBIOLOGY (2021)

Review Biochemistry & Molecular Biology

Insulin and Insulin Resistance in Alzheimer's Disease

Aleksandra Sedzikowska et al.

Summary: Insulin plays multiple roles in the central nervous system, including regulating glucose metabolism, supporting cognition, enhancing neuron outgrowth, etc. Changes in insulin signaling may lead to adverse consequences, such as accelerating brain aging and affecting neuronal plasticity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Clinical Neurology

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

Bruno Dubois et al.

Summary: The use of biomarkers in the diagnosis of Alzheimer's disease has limitations and should be used cautiously in a clinical setting, restricted to individuals with specific phenotypes and positive biomarkers. Biomarker-positive cognitively unimpaired individuals should be considered at-risk for progression to Alzheimer's disease.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

G protein-coupled receptor kinases are associated with Alzheimer's disease pathology

Thais Rafael Guimaraes et al.

Summary: The study identifies a link between G protein-coupled receptor kinases (GRKs) and the pathological phosphorylation and accumulation of tau in Alzheimer's disease (AD), as well as a novel role in regulating the disease's pathological hallmarks. The expression patterns of different GRKs vary in AD patients compared to control subjects, indicating potential involvement in tau phosphorylation and NFT formation.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Review Pharmacology & Pharmacy

Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation

Shehata Anwar et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2020)

Article Neurosciences

Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation

Lei Yang et al.

NEUROBIOLOGY OF DISEASE (2020)

Article Cell Biology

Genetic networks in Parkinson's and Alzheimer's disease

Jack Kelly et al.

AGING-US (2020)

Review Biochemistry & Molecular Biology

Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease

Ansab Akhtar et al.

NEUROCHEMISTRY INTERNATIONAL (2020)

Review Cardiac & Cardiovascular Systems

G protein-coupled receptor kinases as therapeutic targets in the heart

Jessica Pfleger et al.

NATURE REVIEWS CARDIOLOGY (2019)

Article Cell Biology

GRK5 influences the phosphorylation of tau via GSK3 and contributes to Alzheimer's disease

Jianghao Zhao et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Clinical Neurology

Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies

Juan Carlos Polanco et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Article Multidisciplinary Sciences

Quantifying Microglia Morphology from Photomicrographs of Immunohistochemistry Prepared Tissue Using ImageJ

Kimberly Young et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)

Article Multidisciplinary Sciences

Ketamine blocks bursting in the lateral habenula to rapidly relieve depression

Yan Yang et al.

NATURE (2018)

Review Neurosciences

ALZHEIMER DISEASE Rodent models for Alzheimer disease

Juergen Goetz et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Review Pharmacology & Pharmacy

GRK5-A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders

Jhana O. Hendrickx et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Multidisciplinary Sciences

GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability

Minchao He et al.

SCIENTIFIC REPORTS (2016)

Article Medicine, Research & Experimental

cDNA microarray and bioinformatic analysis for the identification of key genes in Alzheimer's disease

Chao Gu et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)

Review Cell Biology

Tau protein kinases: Involvement in Alzheimer's disease

Ludovic Martin et al.

AGEING RESEARCH REVIEWS (2013)

Review Chemistry, Multidisciplinary

A Brief History of G-Protein Coupled Receptors (Nobel Lecture)

Robert J. Lefkowitz

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

Review Multidisciplinary Sciences

Molecular signatures of G-protein-coupled receptors

A. J. Venkatakrishnan et al.

NATURE (2013)

Article Medicine, General & Internal

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Correction Clinical Neurology

Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)

F. Mangialasche et al.

LANCET NEUROLOGY (2011)

Article Biochemistry & Molecular Biology

GRK5 Deficiency Accelerates β-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic Activity

Shaowu Cheng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

G-protein-coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-induced Apoptosis

Xiaoqing Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Clinical Neurology

Alzheimer's disease: clinical trials and drug development

Francesca Mangialasche et al.

LANCET NEUROLOGY (2010)

Article Biochemistry & Molecular Biology

β-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling

Gael Barthet et al.

EMBO JOURNAL (2009)

Article Immunology

GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice

Longxuan Li et al.

JOURNAL OF NEUROINFLAMMATION (2008)

Article Geriatrics & Gerontology

GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment

Zhiming Suo et al.

NEUROBIOLOGY OF AGING (2007)